Wei-Ping Liao

Dr. Wei-Ping Liao

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
JWJie Wang
Jie Wang
ZLZhi-Jian Lin
Zhi-Jian Lin
LLLiu Liu
Liu Liu
HXHai-Qing Xu
Hai-Qing Xu
YSYi-Wu Shi
Yi-Wu Shi
WLWei-Ping Liao
Wei-Ping Liao

9 March 2015 in Human Mutation
Verified
Journal Article
Closed access
PDF file
HMHeng Meng
Heng Meng
HXHai-Qing Xu
Hai-Qing Xu
LYLu Yu
Lu Yu
GLGuo-Wang Lin
Guo-Wang Lin
NHNa He
Na He
WLWei-Ping Liao
Wei-Ping Liao

23 September 2023 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
MZMeng-Wen Zhang
Meng-Wen Zhang
XLXiao-Yu Liang
Xiao-Yu Liang
JWJie Wang
Jie Wang
LGLiang-Di Gao
Liang-Di Gao
HLHan-Jun Liao
Han-Jun Liao
WLWei-Ping Liao
Wei-Ping Liao

9 May 2017 in Neuroscience Bulletin
Verified
Journal Article
Closed access
PDF file
FWFeng Wei
Feng Wei
LYLi-Min Yan
Li-Min Yan
TSTao Su
Tao Su
NHNa He
Na He
ZLZhi-Jian Lin
Zhi-Jian Lin
WLWei-Ping Liao
Wei-Ping Liao

6 June 2017 in Neurology
Verified
Journal Article
Open access
PDF file
YSYi-Wu Shi
Yi-Wu Shi
FMFu-Li Min
Fu-Li Min
DZDong Zhou
Dong Zhou
BQBin Qin
Bin Qin
JWJuan Wang
Juan Wang
WLWei-Ping Liao
Wei-Ping Liao
Objective: To investigate the involvement of human leukocyte antigen (HLA) loci in aromatic antiepileptic drug–induced cutaneous adverse reactions. Methods: A case-control study was performed to detect HLA loci involved in aromatic antiepileptic drug–induced Stevens-Johnson syndrome in a southern Han Chinese population. Between January 1, 2006, and December 31, 2015, 91 cases of Stevens-Johnson syndrome induced by aromatic antiepileptic drugs and 322 matched drug-tolerant controls were enrolled from 8 centers. Important genotypes were replicated in cases with maculopapular eruption and in the meta-analyses of data from other populations. Sequence-based typing determined the HLA-A, HLA-B, HLA-C, and HLA-DRB1 genotypes. Results: HLA-B*15:02 was confirmed as strongly associated with carbamazepine-induced Stevens-Johnson syndrome (p = 5.63 × 10−15). In addition, HLA-A*24:02 was associated significantly with Stevens-Johnson syndrome induced by the aromatic antiepileptic drugs as a group (p = 1.02 × 10−5) and by individual drugs (carbamazepine p = 0.015, lamotrigine p = 0.005, phenytoin p = 0.027). Logistic regression analysis revealed a multiplicative interaction between HLA-B*15:02 and HLA-A*24:02. Positivity for HLA-A*24:02 and/or HLA-B*15:02 showed a sensitivity of 72.5% and a specificity of 69.0%. The presence of HLA-A*24:02 in cases with maculopapular exanthema was also significantly higher than in controls (p = 0.023). Meta-analysis of data from Japan, Korea, Malaysia, Mexico, Norway, and China revealed a similar association. Conclusions: HLA-A*24:02 is a common genetic risk factor for cutaneous adverse reactions induced by aromatic antiepileptic drugs in the southern Han Chinese and possibly other ethnic populations. Pretreatment screening is recommended for people in southern China.

21 August 2019 in Brain
Verified
Journal Article
Closed access
YSYi-Wu Shi
Yi-Wu Shi
QZQi Zhang
Qi Zhang
KCKefu Cai
Kefu Cai
SPSarah Poliquin
Sarah Poliquin
WSWangzhen Shen
Wangzhen Shen
JKJing-Qiong (Katty) Kang
Jing-Qiong (Katty) Kang
Mutations in GABRB3, which encodes the β3 subunit of GABAA receptors, cause variable epilepsy syndromes with autism and intellectual disability. Shi et al. report that mutant β3 subunits reduce expression of wildtype γ2 subunits, which are critical for receptor synaptic clustering. However, they do so to different degrees, contributing to disease heterogeneity.